“…When derived from respiratory isolates, criteria for NTM-LD by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) must be met in order to distinguish colonisation or contaminant from a true pathogen [7] . Pulmonary infections with Mycobacterium kansasii are usually associated with immunosuppression including patients after transplantation, e. g. malignancies, HIV or underlying lung disease [3] . NTM-LD should be diagnosed when NTM-positive patients show pulmonary or systemic symptoms (e.g., dyspnoea, fever, night sweats, weight loss) which correlate with radiographic features on chest radiograph or high-resolution computed tomography (HR-CT) [7] , [8] .…”